NFE2L2 and pulmonary fibrosis: Thus, all of these results suggest that the pharmacological activation of NRF2 by these inducers allows better control of oxidative stress, a decrease pulmonary inflammation and a mitigation of the pulmonary fibrosis by defeating several pathways.